182 related articles for article (PubMed ID: 18716738)
1. Neuromuscular junctional disorders.
Girija AS; Ashraf VV
Indian J Pediatr; 2008 Jul; 75(7):699-702. PubMed ID: 18716738
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
Punga AR; Flink R; Askmark H; Stålberg EV
Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis and treatment of myasthenia gravis.
Levinson AI; Zweiman B; Lisak RP
J Clin Immunol; 1987 May; 7(3):187-97. PubMed ID: 3036906
[No Abstract] [Full Text] [Related]
4. Antibody-mediated disorders of neuromuscular transmission.
Vincent A
Suppl Clin Neurophysiol; 2004; 57():147-58. PubMed ID: 16106615
[No Abstract] [Full Text] [Related]
5. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis.
Stickler DE; Stickler LL
Muscle Nerve; 2007 Jun; 35(6):808-11. PubMed ID: 17221882
[TBL] [Abstract][Full Text] [Related]
6. [Neurophysiological testing in myasthenia syndromes].
Kostera-Pruszczyk A; Rowińska-Marcińska K; Emeryk-Szajewska B
Neurol Neurochir Pol; 2003; 37(1):161-72. PubMed ID: 12910838
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune myasthenia gravis in childhood.
Andrews PI
Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
[TBL] [Abstract][Full Text] [Related]
8. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
9. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and electrophysiological peculiarities of seronegative myasthenia].
Shcherbakova NI; Sanadze AG; Sidnev DV; Rudnichenko VA
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):4-10. PubMed ID: 18427534
[TBL] [Abstract][Full Text] [Related]
12. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
[TBL] [Abstract][Full Text] [Related]
13. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
14. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
Saulat B; Maertens P; Hamilton WJ; Bassam BA
Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
[No Abstract] [Full Text] [Related]
15. [Pathophysiology on the disorder of neuromuscular transmission defects].
Sahashi K; Ibi T
Rinsho Byori; 1995 Sep; 43(9):902-9. PubMed ID: 7474453
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic difficulties in myasthenia gravis].
Bilińska M; Nyka WM
Pol Merkur Lekarski; 2011 Apr; 30(178):277-82. PubMed ID: 21595175
[TBL] [Abstract][Full Text] [Related]
17. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.
Niks EH; Kuks JB; Wokke JH; Veldman H; Bakker E; Verschuuren JJ; Plomp JJ
Muscle Nerve; 2010 Aug; 42(2):283-8. PubMed ID: 20544919
[TBL] [Abstract][Full Text] [Related]
18. [Myasthenia gravis induced by autoantibodies against MuSK].
Shigemoto K; Konishi T; Ohta M
Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
[TBL] [Abstract][Full Text] [Related]
19. Clinical aspects of myasthenia explained.
Verschuuren JJ; Palace J; Gilhus NE
Autoimmunity; 2010 Aug; 43(5-6):344-52. PubMed ID: 20380587
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and clinical classification of autoimmune myasthenia gravis.
Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B
J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
